Skill Checkup: A 58-Year-Old Vaccinated Man With a Painful, Itchy Rash on His Face and Trunk

Heidi Moawad, MD


May 08, 2023

The National Advisory Committee on Immunization (NACI) recommends immunisation with RZV in patients ≥ 50 years of age without contraindications who previously received LZV and who had a prior episode of HZ.

According to the NACI: 'Prior recipients of LZV vaccine will derive additional protection from completion of the two-dose series of RZV given higher and more durable vaccine efficacy across age groups'. The panel adds, 'Individuals with a prior episode of HZ are still at risk of HZ, and a history of HZ is unreliable; therefore, vaccination with RZV in those who report a prior history of HZ will be beneficial'.

RZV is administered as two 0.50 mL intramuscular doses 2-6 months apart. To improve adherence to the second dose, RHZ vaccine may be given on a 0,12 month schedule, with administration at the next annual visit or at the time of the next annual influenza immunisation.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.